King Pharmaceuticals KG European Hospital Liability — Year 4
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's european hospital liability — year 4.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's european hospital liability — year 4?
- King Pharmaceuticals (KG) reported european hospital liability — year 4 of 13.7% in Q4 2025.
- What does european hospital liability — year 4 mean?
- This metric captures the financial performance or claim development for the fourth year of the underwriting cycle within the European Hospital Liability segment. It is essential for evaluating the long-term accuracy of reserve estimations and the ultimate settlement costs for mature claims in this segment.